Jodie Palmer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 4
-
- Prostate Cancer Treatment and Research 5
-
- Cancer Genomics and Diagnostics 3
-
- Estrogen and related hormone effects 3
-
- Lymphoma Diagnosis and Treatment 5
-
- Ovarian cancer diagnosis and treatment 4
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Jonathan CebonMichael CoxDamien KeeMatteo S. CarlinoOliver KleinBen MarkmanAndreas BehrenCraig Underhill
- Partner nations
- AustraliaCanadaUnited States
In The Last Decade
Jodie Palmer
27 papers receiving 806 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 366
- Pulmonary and Respiratory Medicine 274
- Cancer Research 123
- Neurology 79
- Genetics 51
Countries citing papers authored by Jodie Palmer
This map shows the geographic impact of Jodie Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodie Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodie Palmer more than expected).
Fields of papers citing papers by Jodie Palmer
This network shows the impact of papers produced by Jodie Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodie Palmer. The network helps show where Jodie Palmer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jodie Palmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | A gut microbial signature for combination immune checkpoint blockade across cancer typesbreakdown → | 2024 | 67 |
| 5 | 2024 | 2 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 11 | |
| 8 | 2020 | 116 | |
| 9 | 2020 | 2 | |
| 10 | 2019 | 1 | |
| 11 | A genome wide association study of survival in locally invasive melanoma | 2014 | 2 |
| 12 | 2008 | 12 | |
| 13 | 2007 | 142 | |
| 14 | 2007 | 51 | |
| 15 | 2006 | 30 | |
| 16 | 2005 | 12 | |
| 17 | 2004 | 36 | |
| 18 | 2004 | 16 | |
| 19 | 2004 | 17 | |
| 20 | Inhibition screening data using sarcoma 180 and adenocarcinoma E0771. | 1955 | 2 |
About Jodie Palmer
Jodie Palmer is a scholar working on Oncology, Reproductive Medicine and Cancer Research, having authored 29 papers that have together received 813 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Prostate Cancer Treatment and Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers), CAR-T cell therapy research (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Estrogen and related hormone effects (3 papers), Cancer Genomics and Diagnostics (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Oncology (366 citations), Pulmonary and Respiratory Medicine (274 citations) and Cancer Research (123 citations). Jodie Palmer has collaborated with scholars based in Australia, Canada and United States. Frequent co-authors include Jonathan Cebon, Michael Cox, Damien Kee, Matteo S. Carlino, Oliver Klein, Ben Markman, Andreas Behren, Craig Underhill, Michael Michael and Louise Jackett. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.